Thulium Laser and KeraFactor for the Treatment of Androgenetic Alopecia

Inclusion Criteria: * Subject must voluntarily sign and date an IRB approved informed consent form * Subjects with diagnosis of androgenetic alopecia with hair loss recorded over the past 6 months. (Ludwig Savin Scale: Class I-4, II-1, II-2 for females and Norwood Hamilton Class 3-4 for males * Able to read, understand and voluntarily provide written informed consent. * Healthy male or female, ≥ 18 years of age at time of informed consent up to 65 years of age, seeking treatment for hair loss. * Subject is determined to be healthy, non-smoker who agrees not to make any changes to their daily hair treatment regime during the study. * Subjects able and willing to comply with the treatment protocol and follow-up schedule and requirements. * Understands and accepts the obligation not to undergo any other procedures in the areas to be treated through the follow-up period. * Women of child-bearing age are required to be using a reliable, non-hormonal method of birth control for the duration of the study. Subjects will be asked to have a negative Urine Pregnancy test at baseline. Exclusion Criteria: * Subjects does not have the capacity to consent to the study * Subject has other types of alopecia of the scalp (i.g., alopecia areata, scarring alopecia) * Use of minoxidil or 5-alpha reductase inhibitors (i.e., finasteride, dutasteride) 3 months prior to screening date. * Any medical condition that in the consideration of the investigator, would present an increased risk of a photosensitivity reaction to the subject. * Pregnant in the last 12 months, intending to become pregnant, postpartum or nursing in the last 12 months. * Any previous surgical procedure in the treatment area in the past 12 months, or major surgery in the last 6 months. * History of immunosuppression/immune deficiency disorders (including AIDS and HIV infection), and/or any history of systemic chemotherapy for prior 12 months. * History or current use of the following prescription medications: Immunosuppressive medications/biologics, 6 months prior to and during the study. Accutane or other systemic retinoids within the past twelve months. * Smoking or vaping in the past 12 months. * History of hyperlipidemia, diabetes mellitus, hepatitis, or bleeding disorders. * History of major depressive disorders or endocrine disorders including but not limited to; hypothyroidism, Hashimoto's thyroiditis, or hyperthyroidism as well as Polycystic Ovarian Syndrome (PCOS) in females.